mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |